HSK16149 20mg BID
Sponsors
Haisco Pharmaceutical Group Co., Ltd.
Conditions
Diabetic Peripheral Neuropathic PainHerpetic NeuralgiaPostherpetic Neuralgia
Phase 2
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain
NCT04647773
Start: 2020-12-02End: 2022-11-16Target: 687Updated: 2020-12-01
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia
CompletedNCT05763550
Start: 2023-02-27End: 2023-08-07Updated: 2023-11-08
Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin
RecruitingNCT06490484
Start: 2024-04-19End: 2024-07-14Target: 90Updated: 2024-07-08